Eduardo Bruno Martins's most recent trade in Sagimet Biosciences Inc - Ordinary Shares - Class A was a trade of 8,277 Series A Common Stock done at an average price of $9.1 . Disclosure was reported to the exchange on July 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.13 per share. | 21 Jul 2025 | 8,277 | 106,936 | - | 9.1 | 75,607 | Series A Common Stock |
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 138,000 | 138,000 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 34,000 | 115,213 | - | 0 | Series A Common Stock | |
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.10 per share. | 19 Jul 2024 | 8,357 | 81,213 | - | 3.1 | 25,910 | Series A Common Stock |
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 198,132 | 198,132 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 198,132 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 44,009 | 44,009 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | Eduardo Bruno Martins | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 44,009 | 0 | - | - | Stock Option (Right to Buy) |